December 9, 2021
Re: Opuwo’s Feasibility Study
Dear CLA Board, Dear Blair,
As a long-time shareholder of CLA I request answers to the following questions:
1. Why was there no updated Scoping Study for Opuwo?
2. And, given there never was an updated Scoping Study (or Pre-Feasibility Study), why wereshareholders never informed as to the reason why?
3. Is, in your opinion, such behavior in line with ASX regulation, and more generally speaking,is, in your opinion, such behavior ethical? Stated differently, if a company repeatedly andenthusiastically refers to an imminent updated Scoping Study (or Pre-Feasibility Study)and by doing so lures in investors, do you think it is ethical to (a) never produce such astudy and (b) never explain why there never was such a study?
Sincerely,
Columbo
- Forums
- ASX - By Stock
- Ann: Change of Director's Interest Notice - BS
December 9, 2021Re: Opuwo’s Feasibility StudyDear CLA Board,...
- There are more pages in this discussion • 37 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add CLA (ASX) to my watchlist
(20min delay)
|
|||||
Last
1.1¢ |
Change
0.000(0.00%) |
Mkt cap ! $26.70M |
Open | High | Low | Value | Volume |
1.2¢ | 1.2¢ | 1.1¢ | $2.476K | 215.9K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 193793 | 1.1¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
1.2¢ | 4230745 | 7 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 193793 | 0.011 |
19 | 18386320 | 0.010 |
16 | 5517623 | 0.009 |
3 | 744950 | 0.008 |
2 | 195000 | 0.007 |
Price($) | Vol. | No. |
---|---|---|
0.012 | 4230745 | 7 |
0.013 | 5380000 | 5 |
0.014 | 3630775 | 5 |
0.015 | 2610097 | 7 |
0.016 | 1786071 | 4 |
Last trade - 16.10pm 02/05/2024 (20 minute delay) ? |
|
|||||
Last
1.1¢ |
  |
Change
0.000 ( 8.33 %) |
|||
Open | High | Low | Volume | ||
1.2¢ | 1.2¢ | 1.1¢ | 200000 | ||
Last updated 11.20am 02/05/2024 ? |
Featured News
CLA (ASX) Chart |
The Watchlist
RDN
RAIDEN RESOURCES LIMITED
Dusko Ljubojevic, MD
Dusko Ljubojevic
MD
SPONSORED BY The Market Online